Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection

Annals of the New York Academy of Sciences

Volumn 1372, Issue 1, 2016, Pages 29-41

  Broecker, Felix ^a,b,c   Klumpp, Jochen ^d   Moelling, Karin ^a,b  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^d ETH ZURICH   (Switzerland)

Author keywords

Clostridium difficile; fecal microbiota therapy; megavirome; phages; virome

Indexed keywords

ARTICLE; BACTERIOPHAGE TYPING; CHLOROVIRUS; CLOSTRIDIUM DIFFICILE INFECTION; ENTEROPATHY; FECAL MICROBIOTA TRANSPLANTATION; FECAL VIROME; HUMAN; INFLAMMATION; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; VIRUS; VIRUS TRANSMISSION;

EID: 84978923047     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13100     Document Type: Article

References (116)

1. Lo Vecchio, A. & G.M. Zacur. 2012. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr. Opin. Gastroenterol. 28: 1–9.
2. Lessa, F.C., C.V. Gould & L.C. McDonald. 2012. Current status of Clostridium difficile infection epidemiology. Clin. Infect. Dis. 55(Suppl. 2): S65–S70.
3. Lessa, F.C., L.G. Winston, L.C. McDonald, et al. 2015. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372: 2369–2370.
4. McDonald, L.C., G.E. Killgore, A. Thompson, et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353: 2433–2441.
5. Kelly, C.P. & J.T. LaMont. 2008. Clostridium difficile—more difficult than ever. N. Engl. J. Med. 359: 1932–1940.
6. Oldfield IV, E.C., E.C. Oldfield III & D.A. Johnson. 2014. Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J. Gastrointest. Phamacol. Ther. 5: 1–26.
7. Chang, J.Y., D.A. Antonopoulos, A. Kalra, et al. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile–associated diarrhea. J. Infect. Dis. 197: 435–438.
8. Figueroa, I., S. Johnson, S.P. Sambol, et al. 2012. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin. Infect. Dis. 55(Suppl. 2): S104–S109.
9. Gough, E., H. Shaikh & A.R. Manges. 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53: 994–1002.
10. Rao, K. & N. Safdar. 2016. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J. Hosp. Med. 11: 56–61.
11. Cohen, N.A., R. Ben Ami, H. Guzner-Gur, et al. 2015. Fecal microbiota transplantation for Clostridium difficile-associated diarrhea. Isr. Med. Assoc. J. 17: 510–514.
12. Borody, T.J. & A. Khoruts. 2011. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9: 88–96.
13. Lübbert, C., E. John & L. von Müller. 2014. Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch. Ärztebl. Int. 111: 723–731.
14. Eiseman, B., W. Silen, G.S. Bascom, et al. 1958. Fecal enema as an adjunct in the treatment of pseudomembraneous enterocolitis. Surgery 44: 854–859.
15. Kassam, Z., C.H. Lee, Y. Yuan, et al. 2014. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am. J. Gastroenterol. 108: 500–508.
16. van Nood, E., A. Vrieze, M. Nieuwdorp, et al. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368: 407–415.
17. Cammarota, G., L. Masucci, G. Ianiro, et al. 2015. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment. Pharmacol. Ther. 41: 835–843.
18. Youngster, I., J. Sauk, C. Pindar, et al. 2014. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin. Infect. Dis. 58: 1515–1522.
19. Turnbaugh, P.J., R.E. Ley, M. Hamady, et al. 2007. The human microbiome project. Nature 449: 804–810.
20. Qin, J., R. Li, J. Raes, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
21. Hoffmann, C., S. Dollive, S. Grunberg, et al. 2013. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One 8: e66019.
22. Reyes, A., M. Haynes, N. Hanson, et al. 2010. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466: 334–338.
23. Reyes, A., N.P. Semenkovich, K. Whiteson, et al. 2012. Going viral: next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 10: 607–617.
24. Breitbart, M., I. Hewson, B. Felts, et al. 2003. Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 185: 6220–6223.
25. Dalmasso, M., C. Hill & R.P. Ross. 2014. Exploiting gut bacteriophages for human health. Trends Microbiol. 22: 399–405.
26. Scarpellini, E., G. Ianiro, F. Attili, et al. 2015. The human gut microbiota and virome: potential therapeutic implications. Dig. Liver Dis. 47: 1007–1012.
27. Bielaszewska, M., R. Prager, R. Köck, et al. 2007. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl. Environ. Microbiol. 73: 3144–3150.
28. Ogilvie, L.A., L.D. Bowler, J. Caplin, et al. 2013. Genome signature-based dissection of human gut metagenomes to extract subliminal viral sequences. Nat. Commun. 4: 2420.
29. Modi, S.R., H.H. Lee, C.S. Spina & J.J. Collins. 2013. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499: 219–222.
30. Roux, S., M. Krupovic, A. Poulet, et al. 2012. Evolution and diversity of the Microviridae viral family through a collection of 81 new complete genomes from virome reads. PLoS One 7: e40418.
31. Wagner, P.L., D.W. Acheson & M.K. Waldor. 2001. Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect. Immun. 69: 1934–1937.
32. Keen, E.C. 2012. Paradigms of pathogenesis: targeting the mobile genetic elements of disease. Front. Cell. Infect. Microbiol. 2: 161.
33. Norman, J.M., S.A. Handley, M.T. Baldridge, et al. 2015. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160: 447–460.
34. Lepage, P., J. Colombet, P. Marteau, et al. 2008. Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 57: 424–425.
35. Meessen-Pinard, M., O. Sekulovic & L.C. Fortier. 2012. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl. Environ. Microbiol. 78: 7662–7670.
36. Broecker, F., M. Kube, J. Klumpp, et al. 2013. Analysis of the intestinal microbiome of a recovered Clostridium difficile patient after fecal transplantation. Digestion 88: 243–251.
37. Broecker, F., J. Klumpp, M. Schuppler, et al. 2015. Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Cold Spring Harb. Mol. Case Stud. 2: a000448.
38. Dutta, S.K., M. Girotra, S. Garg, et al. 2014. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 12: 1572–1576.
39. Hamilton, M.J., A.R. Weingarden, T. Unno, et al. 2013. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4: 125–135.
40. Seekatz, A.M., J. Aas, C.E. Gessert, et al. 2014. Recovery of the gut microbiome following fecal microbiota transplantation. MBio 5: e00893-14.
41. Shahinas, D., M. Silverman, T. Sittler, et al. 2012. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 3: e00338-12.
42. Shankar, V., M.J. Hamilton, A. Khoruts, et al. 2014. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2: 13.
43. Song, Y., S. Garg, M. Girotra, et al. 2013. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One 8: e81330.
44. Walia, R., S. Garg, Y. Song, et al. 2014. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome. J. Pediatr. Gastroenterol. Nutr. 59: 565–570.
45. Weingarden, A.R., C. Chen, A. Bobr, et al. 2013. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306: G310–G319.
46. Weingarden, A., A. González, Y. Vázquez-Baeza, et al. 2015. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome 3: 10.
47. Huson, D.H., A.F. Auch, J. Qi & S.C. Schuster. 2007. MEGAN analysis of metagenomic data. Genome Res. 17: 377–386.
48. Eckburg, P.B., E.M. Bik, C.N. Bernstein, et al. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635–1638.
49. Spor, A., O. Koren & R. Ley. 2011. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9: 279–290.
50. Dethlefsen, L., S. Huse, M.L. Sogin & D.A. Relman. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6: e280.
51. Antharam, V.C., E. Li, A. Ishmael, et al. 2013. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51: 2884–2892.
52. Guilloteau, P., L. Martin, V. Eeckhaut, et al. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 23: 366–384.
53. Hamer, H.M., D. Jonkers, K. Venema, et al. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27: 104–119.
54. Collado, M.C., M. Derrien, E. Isolauri, et al. 2007. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73: 7767–7770.
55. Khamsi, R. 2015. A gut feeling about immunity. Nat. Med. 21: 674–676.
56. Schneeberger, M., A. Everard, A.G. Gómez-Valadés, et al. 2015. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5: 16643.
57. Everard, A., C. Belzer, L. Geurts, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110: 9066–9071.
58. Zhang, X., D. Shen, Z. Fang, et al. 2013. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8: e71108.
59. Miquel, S., R. Martín, O. Rossi, et al. 2013. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16: 255–261.
60. Quévrain, E., M.A. Maubert, C. Michon, et al. 2016. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65: 415–425.
61. Sokol, H., B. Pigneur, L. Watterlot, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105: 16731–16736.
62. Minot, S., A. Bryson, C. Chehoud, et al. 2013. Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. U.S.A. 110: 12450–12455.
63. Barr, J.J., R. Auro, M. Furlan, et al. 2013. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. U.S.A. 110: 10771–10776.
64. Ogilvie, L.A., J. Caplin, C. Dedi, et al. 2012. Comparative (meta)genomic analysis and ecological profiling of human gut-specific bacteriophage φB124-14. PLoS One 7: e35053.
65. Born, Y., L. Fieseler, J. Klumpp, et al. 2014. The tail-associated depolymerase of Erwinia amylovora phage L1 mediates host cell adsorption and enzymatic capsule removal, which can enhance infection by other phage. Environ. Microbiol. 16: 2168–2180.
66. Van Etten, J.L. 2003. Unusual life style of giant chlorella viruses. Annu. Rev. Genet. 37: 153–195.
67. Vollaard, E.J. & H.A. Clasener. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38: 409–414.
68. Seekatz, A.M. & V.B. Young. 2014. Clostridium difficile and the microbiota. J. Clin. Invest. 124: 4182–4189.
69. Shin, N.R., T.W. Whon & J.W. Bae. 2015. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33: 496–503.
70. Górski, A., M. Kniotek, A. Perkowska-Ptasińska, et al. 2006. Bacteriophages and transplantation tolerance. Transplant. Proc. 38: 331–333.
71. Miedzybrodzki, R., W. Fortuna, B. Weber-Dabrowska & A. Górski. 2009. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin. Exp. Med. 9: 303–312.
72. Dao, M.C., A. Everard, J. Aron-Wisnewsky, et al. 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65: 426–436.
73. Faith J.J., J.L. Guruge, M. Charbonneau, et al. 2013. The long-term stability of the human gut microbiota. Science 341: 1237439.
74. Petrof, E.O., G.B. Gloor, S.J. Vanner, et al. 2013. Stool substitute transplant for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome 1: 3.
75. Weinbauer, M.G. 2004. Ecology of prokaryotic viruses. FEMS Microbiol. Rev. 28: 127–181.
76. Krupovic, M. & P. Forterre. 2011. Microviridae goes temperate: microvirus-related proviruses reside in the genomes of Bacteroidetes. PLoS One 6: e19893.
77. Minot, S., R. Sinha, J. Chen, et al. 2011. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21: 1616–1625.
78. Chehoud, C., A. Dryga, Y. Hwang, et al. 2016. Transfer of viral communities between human individuals during fecal microbiota transplantation. MBio 7: e00322-16.
79. Reardon, S. 2014. Phage therapy gets revitalized. Nature 510: 15–16.
80. Sarker, S.A., S. Sultana, G. Reuteler, et al. 2016. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4: 124–137.
81. Hargreaves, K.R. & M.R. Clokie. 2014. Clostridium difficile phages: still difficult? Front. Microbiol. 5: 184.
82. Meader, E., M.J. Mayer, D. Steverding, et al. 2013. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe 22: 25–30.
83. Nale, J.Y., J. Spencer, K.R. Hargreaves, et al. 2015. Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo. Antimicrob. Agents Chemother. 60: 968–981.
84. Roberts, A.P., E. Allan & P. Mullany. 2014. The impact of horizontal gene transfer on the biology of Clostridium difficile. Adv. Microb. Physiol. 65: 63–82.
85. Quesada-Gómez, C., D. López-Ureña, L. Acuña-Amador, et al. 2015. Emergence of an outbreak-associated Clostridum difficile variant with increased virulence. J. Clin. Microbiol. 53: 1216–1226.
86. Martel, B. & S. Moineau. 2014. CRISPR-Cas: an efficient tool for genome editing of virulent bacteriophages. Nucleic Acids Res. 42: 9504–9513.
87. Ando, H., S. Lemire, D.P. Pires & T.K. Lu. 2015. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst. 1: 187–196.
88. Allard, A., B. Albinsson & G. Wadell. 1992. Detection of adenoviruses in stools from healthy persons and patients with diarrhea by two-step polymerase chain reaction. J. Med. Virol. 37: 149–157.
89. Atkinson, R.L., N.V. Dhurandhar, D.B. Allison, et al. 2005. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. (Lond.) 29: 281–286.
90. Ryan, J.L., Y.J. Shen, D.R. Morgan, et al. 2012. Epstein–Barr virus infection is common in inflamed gastrointestinal mucosa. Dig. Dis. Sci. 57: 1887–1898.
91. Dimitroulia, E., V.C. Pitiriga, E.T. Piperaki, et al. 2013. Inflammatory bowel disease exacerbation associated with Epstein–Barr virus infection. Dis. Colon Rectum 56: 322–327.
92. Iyer, V.H., J. Augustine, A.B. Pulimood, et al. 2013. Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis. Indian J. Gasteroenterol. 32: 115–118.
93. Antonic, V., A. Stojadinovic, K.E. Kester, et al. 2013. Significance of infectious agents in colorectal cancer development. J. Cancer 4: 227–240.
94. Lagier, J.C., F. Armougom, M. Million, et al. 2012. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18: 1185–1193.
95. Colson, P., L. Fancello, G. Gimenez, et al. 2013. Evidence of the megavirome in humans. J. Clin. Virol. 57: 191–200.
96. Kutikhin, A.G., A.E. Yuzhalin & E.B. Brusina. 2014. Mimiviridae, Marseilleviridae, and virophages as emerging human pathogens causing healthcare-associated infections. GMS Hyg. Infect. Control 9: Doc16.
97. Finkbeiner, S.R., A.F. Allred, P.I. Tarr, et al. 2008. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 4: e1000011.
98. Yolken, R.H., L. Jones-Brando, D.D. Dunigan, et al. 2014. Chlorovirus ATCV-1 is part of the human oropharyngeal virome and is associated with changes in cognitive functions in humans and mice. Proc. Natl. Acad. Sci. U.S.A. 111: 16106–16111.
99. Vanchiere, J.A., S. Abudayyeh, C.M. Copeland, et al. 2009. Polyomavirus shedding in the stool of healthy adults. J. Clin. Microbiol. 47: 2388–2391.
100. Smits, S.L., C.M. Schapendonk, J. van Beek, et al. 2014. New viruses in idiopathic human diarrhea cases, the Netherlands. Emerg. Infect. Dis. 20: 1218–1222.
101. Li, L., A. Kapoor, B. Slikas, et al. 2010. Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J. Virol. 84: 1674–1682.
102. Popgeorgiev, N., S. Temmam, D. Raoult & C. Desnues. 2013. Describing the silent human virome with an emphasis on giant viruses. Intervirology 56: 395–412.
103. Zhang, T., M. Breitbart, W.H. Lee, et al. 2006. RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol. 4: e3.
104. Critical views in gastroenterology & hepatology. 2014. Fecal microbiota transplantation: where is it leading? Gastroenterol. Hepatol. (N.Y.) 10: 307–309.
105. Alang, N. & C.R. Kelly. 2015. Weight gain after fecal microbiota transplantation. Open Forum Infect. Dis. 2: ofv004.
106. Kim, M.S. & J.W. Bae. 2016. Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice. Environ. Microbiol. 18: 1498–1510.
107. Rohlke, F. & N. Stollman. 2012. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap. Adv. Gastroenterol. 5: 403–420.
108. Petro, T.M., I.V Agarkova, Y. Zhou, et al. 2015. Response of mammalian macrophages to challenge with the chlorovirus Acanthocystis turfacea chlorella virus 1. J. Virol. 89: 12096–12107.
109. Ghigo, E., J. Kartenbeck, P. Lien, et al. 2008. Amoebal pathogen mimivirus infects macrophages through phagocytosis. PLoS Pathog. 4: e1000087.
110. Siddiqui, R. & N.A. Khan. 2012. Acanthamoebae is an evolutionary ancestor of macrophages: a myth or reality? Exp. Parasitol. 130: 95–97.
111. Cryan, J.F. & T.G. Dinan. 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13: 701–712.
112. Duerkop, B.A. & L.V. Hooper. 2013. Resident viruses and their interactions with the immune system. Nat. Immunol. 14: 654–659.
113. Kernbauer, E., Y. Ding & K. Cadwell. 2014. An enteric virus can replace the beneficial function of commensal bacteria. Nature 516: 94–98.
114. Brandt, L.J., O.C. Aroniadis, M. Mellow, et al. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107: 1079–1087.
115. Alvarez-Lafuente, R., B. Fernández-Gutiérrez, S. de Miguel, et al. 2005. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann. Rheum. Dis. 64: 1357–1359.
116. Sunagawa, S., L.P. Coelho, S. Chaffron, et al. 2015. Ocean plankton. Structure and function of the global ocean microbiome. Science 348: 1261359.